Central Bank & Trust CO Regeneron Pharmaceuticals, Inc. Transaction History

Central Bank & Trust CO

$718 Million
Q2 2024

A detailed history of Central Bank & Trust CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Central Bank & Trust CO holds 1,298 shares of REGN stock, worth $1.49 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

1,298

Previous 1,376 5.67%

Holding current value

$1.49 Million

Previous $1.32 Million 3.02%

% of portfolio

0.19%

Previous 0.19%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$883.2 - $1071.19 $68,889 - $83,552	-78 Reduced 5.67%	1,298 $1.36 Million
Q1 2024 Apr 11, 2024	SELL	$902.69 - $993.35 $100,198 - $110,261	-111 Reduced 7.46%	1,376 $1.32 Million
Q4 2023 Jan 09, 2024	SELL	$775.18 - $881.7 $73,642 - $83,761	-95 Reduced 6.01%	1,487 $1.31 Million
Q3 2023 Oct 10, 2023	BUY	$692.45 - $844.37 $5,539 - $6,754	8 Added 0.51%	1,582 $1.3 Million
Q2 2023 Jul 13, 2023	SELL	$700.03 - $830.35 $23,100 - $27,401	-33 Reduced 2.05%	1,574 $1.13 Million
Q1 2023 Apr 13, 2023	BUY	$680.49 - $826.97 $81,658 - $99,236	120 Added 8.07%	1,607 $1.32 Million
Q4 2022 Jan 18, 2023	SELL	$705.89 - $766.39 $24,000 - $26,057	-34 Reduced 2.24%	1,487 $0
Q3 2022 Oct 20, 2022	SELL	$573.97 - $724.32 $243,937 - $307,836	-425 Reduced 21.84%	1,521 $1.05 Million
Q2 2022 Jul 22, 2022	SELL	$548.35 - $738.84 $305,979 - $412,272	-558 Reduced 22.28%	1,946 $1.15 Million
Q1 2022 Apr 18, 2022	BUY	$595.12 - $698.43 $67,248 - $78,922	113 Added 4.73%	2,504 $1.75 Million
Q4 2021 Jan 18, 2022	BUY	$543.48 - $670.97 $65,217 - $80,516	120 Added 5.28%	2,391 $1.51 Million
Q3 2021 Oct 19, 2021	SELL	$574.03 - $680.96 $49,366 - $58,562	-86 Reduced 3.65%	2,271 $1.37 Million
Q2 2021 Jul 16, 2021	SELL	$472.8 - $558.54 $513,460 - $606,574	-1,086 Reduced 31.54%	2,357 $1.32 Million
Q1 2021 Apr 20, 2021	SELL	$446.73 - $548.2 $444,049 - $544,910	-994 Reduced 22.4%	3,443 $1.63 Million
Q4 2020 Jan 12, 2021	SELL	$478.3 - $607.98 $1.64 Million - $2.09 Million	-3,437 Reduced 43.65%	4,437 $2.14 Million
Q3 2020 Oct 08, 2020	BUY	$544.75 - $658.21 $172,141 - $207,994	316 Added 4.18%	7,874 $4.41 Million
Q2 2020 Jul 15, 2020	BUY	$493.32 - $643.92 $3.72 Million - $4.86 Million	7,549 Added 83877.78%	7,558 $4.71 Million
Q1 2020 Apr 14, 2020	BUY	$336.18 - $494.43 $3,025 - $4,449	9 New	9 $3,000
Q3 2019 Oct 23, 2019	SELL	$273.46 - $318.39 $2,461 - $2,865	-9 Closed	0 $0
Q2 2019 Jul 16, 2019	SELL	$299.6 - $414.82 $3.32 Million - $4.6 Million	-11,082 Reduced 99.92%	9 $3,000
Q1 2019 Apr 22, 2019	BUY	$372.08 - $439.57 $268,269 - $316,929	721 Added 6.95%	11,091 $4.55 Million
Q4 2018 Jan 17, 2019	BUY	$335.82 - $403.04 $3.48 Million - $4.18 Million	10,370 New	10,370 $3.87 Million

Others Institutions Holding REGN

# of Institutions

1,461

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $123B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Bank & Trust CO with notifications on news.

Account

Central Bank & Trust CO Regeneron Pharmaceuticals, Inc. Transaction History